Clinical trials
Phase 2 Fever trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
26 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 2 |
| 2004 | 2 |
| 2006 | 2 |
| 2007 | 1 |
| 2009 | 1 |
| 2010 | 3 |
| 2011 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 20 |
| Not yet recruiting | 2 |
| Withdrawn | 2 |
| Terminated | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 3 |
| Amgen | 1 |
| Avicenna Medical College Lahore | 1 |
| Canadian Critical Care Trials Group | 1 |
| Cellerant Therapeutics | 1 |
| Charite University, Berlin, Germany | 1 |
| Far East Bio-Tec Co., Ltd | 1 |
| Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1 |
| Malaria Vaccine and Drug Development Center | 1 |
| Melanoma Institute Australia | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fever | 26 |
| Neutropenia | 4 |
| Infections | 3 |
| Abdominal Pain | 2 |
| Anemia | 2 |
| Cough | 2 |
| Fatigue | 2 |
| Hyperthermia | 2 |
| Influenza, Human | 2 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 |
Trials
Showing 51 to 26 of 26. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.